Winter Charles M., Chief Technical Officer of Janux Therapeutics ($JANX), made one open market sale of company shares in the last year, totaling about $33,000. His latest sale occurred on January 2, 2026. Among 11,678 insiders with sales, his amount ranks 10,739th, well below the average of $8.6 million over 6.4 transactions. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Janux Therapeutics, Inc. | $JANX | Winter Charles M. | Chief Technical Officer | S | Common Stock | 2401 | $13.73 | 77,721.0000 | 62,023,685 | 3.00% | 0.00% |
| Jan. 2, 2026 | Janux Therapeutics, Inc. | $JANX | Winter Charles M. | Chief Technical Officer | A | Common Stock | 28600 | $0.00 | 106,321.0000 | 62,023,685 | 36.80% | 0.05% |
| Jan. 2, 2026 | Janux Therapeutics, Inc. | $JANX | Winter Charles M. | Chief Technical Officer | A | Stock option (right to buy) | 100100 | $0.00 | 100,100.0000 | 62,023,685 | 9999.99% | 0.16% |
| Jan. 2, 2025 | Janux Therapeutics, Inc. | $JANX | Winter Charles M. | Chief Technical Officer | A | Common Stock | 23000 | $0.00 | 77,288.0000 | 53,751,480 | 42.37% | 0.04% |
| Jan. 2, 2025 | Janux Therapeutics, Inc. | $JANX | Winter Charles M. | Chief Technical Officer | A | Stock option (right to buy) | 80500 | $0.00 | 80,500.0000 | 53,751,480 | 9999.99% | 0.15% |
| Jan. 2, 2024 | Janux Therapeutics, Inc. | $JANX | Winter Charles M. | Chief Technical Officer | A | Stock Option (right to buy) | 111000 | $0.00 | 111,000.0000 | 44,016,283 | 9999.99% | 0.25% |